These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 1425297)

  • 21. BiP: a new biologic immunomodulator for the treatment of rheumatoid arthritis.
    Panayi G; Corrigall V
    Autoimmun Rev; 2004 Jun; 3 Suppl 1():S16-7. PubMed ID: 15309771
    [No Abstract]   [Full Text] [Related]  

  • 22. The T cell receptor in autoimmune diseases.
    Bluestone JA; Spencer C; Hirsch R
    J Rheumatol Suppl; 1992 Apr; 33():75-7. PubMed ID: 1534379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superantigens and their role in infectious disease.
    Schafer R; Sheil JM
    Adv Pediatr Infect Dis; 1995; 10():369-90. PubMed ID: 7718212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New treatments of rheumatoid arthritis for future use].
    Cantagrel A; Mazières B
    Rev Rhum Ed Fr; 1993 May; 60(5 Pt 2):45S-52S. PubMed ID: 8162008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of T lymphocytes in the immunotherapy of tumours.
    Brondz BD; Balashov KE
    Biomed Sci; 1991; 2(5):441-9. PubMed ID: 1840832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MHC class II molecules regulate growth in human T cells.
    Nielsen M; Odum N; Bendtzen K; Ryder LP; Jakobsen BK; Svejgaard A
    Exp Clin Immunogenet; 1994; 11(1):23-32. PubMed ID: 7913331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitors.
    Prud'homme GJ
    J Gene Med; 2000; 2(4):222-32. PubMed ID: 10953913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New therapeutic possibilities. Future aspects].
    Rubbert A; Burmester GR
    Internist (Berl); 1993 Sep; 34(9):841-51. PubMed ID: 8407201
    [No Abstract]   [Full Text] [Related]  

  • 30. Heat shock proteins in health and disease.
    Fałkowska-Podstawka M; Wernicki A
    Pol J Vet Sci; 2003; 6(1):61-70. PubMed ID: 12675471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New therapies in development for autoimmune diseases: their rationale for combination treatment.
    Strand V
    Springer Semin Immunopathol; 2001; 23(1-2):43-61. PubMed ID: 11455860
    [No Abstract]   [Full Text] [Related]  

  • 32. [Trends in adjuvant pathogenetic therapy of infectious and autoimmune diseases].
    Nikitin AV
    Antibiot Khimioter; 2000; 45(12):17-22. PubMed ID: 11212487
    [No Abstract]   [Full Text] [Related]  

  • 33. Superantigens: biology, immunology, and potential role in disease.
    Drake CG; Kotzin BL
    J Clin Immunol; 1992 May; 12(3):149-62. PubMed ID: 1400895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New therapeutic approaches to autoimmune diseases].
    Amoura Z; Piette JC
    Presse Med; 2006 Apr; 35(4 Pt 2):709-13. PubMed ID: 16614619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomodulators.
    Schrieber L
    Agents Actions Suppl; 1988; 24():254-64. PubMed ID: 3055878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Monoclonal antibodies as an immunotherapy of rheumatoid arthritis].
    Abe T; Takeuchi T
    Nihon Rinsho; 1998 Mar; 56(3):776-81. PubMed ID: 9549372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti adhesion therapy].
    Yamada A; Murakami M; Uede T
    Nihon Rinsho; 1995 Mar; 53(3):761-70. PubMed ID: 7699919
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapeutic immuno-intervention in rheumatoid polyarthritis].
    Sany J
    Rev Med Interne; 1999; 20 Suppl 1():33S-34S. PubMed ID: 10436913
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis.
    Cook AD; Visvanathan K
    Expert Opin Ther Targets; 2004 Oct; 8(5):375-90. PubMed ID: 15469389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heat shock protein bystander antigens for peptide immunotherapy in autoimmune disease.
    Zonneveld-Huijssoon E; Albani S; Prakken BJ; van Wijk F
    Clin Exp Immunol; 2013 Jan; 171(1):20-9. PubMed ID: 23199319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.